Cargando…

Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists

It has now been demonstrated that the μ, δ(1), δ(2), and κ(1) opioid receptor (OR) agonists represent the most promising group of opioids for the creation of drugs enhancing cardiac tolerance to the detrimental effects of ischemia/reperfusion (I/R). Opioids are able to prevent necrosis and apoptosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maslov, Leonid N, Khaliulin, Igor, Oeltgen, Peter R., Naryzhnaya, Natalia V., Pei, Jian‐Ming, Brown, Stephen A., Lishmanov, Yury B., Downey, James M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082499/ https://www.ncbi.nlm.nih.gov/pubmed/27197922 http://dx.doi.org/10.1002/med.21395

Ejemplares similares

Takotsubo Syndrome: Clinical Manifestations, Etiology and Pathogenesis
por: Prokudina, Ekaterina S., et al.
Publicado: (2021)

Reperfusion Cardiac Injury: Receptors and the Signaling Mechanisms
por: Maslov, Leonid N., et al.
Publicado: (2022)

Is oxidative stress of adipocytes a cause or a consequence of the metabolic syndrome?
por: Maslov, Leonid N., et al.
Publicado: (2018)

The Infarct-Reducing Effect of the δ(2) Opioid Receptor Agonist Deltorphin II: The Molecular Mechanism
por: Popov, Sergey V., et al.
Publicado: (2023)

Trigger, Signaling Mechanism and End Effector of Cardioprotective Effect of Remote Postconditioning of Heart
por: Maslov, Leonid N., et al.
Publicado: (2019)

The cardioprotective and antiarrhythmic effects of Nardostachys chinensis in animal and cell experiments
por: Li, Min, et al.
Publicado: (2017)

Mechanisms Underlying Antiarrhythmic Properties of Cardioprotective Agents Impacting Inflammation and Oxidative Stress
por: Andelova, Katarina, et al.
Publicado: (2022)

Consecutive pharmacological activation of PKA and PKC mimics the potent cardioprotection of temperature preconditioning
por: Khaliulin, Igor, et al.
Publicado: (2010)

Cardioprotection of Immature Heart by Simultaneous Activation of PKA and Epac: A Role for the Mitochondrial Permeability Transition Pore
por: Lewis, Martin John, et al.
Publicado: (2022)

Preconditioning or Postconditioning with 8-Br-cAMP-AM Protects the Heart against Regional Ischemia and Reperfusion: A Role for Mitochondrial Permeability Transition
por: Khaliulin, Igor, et al.
Publicado: (2021)

δ-Opioid Receptor as a Molecular Target for Increasing Cardiac Resistance to Reperfusion in Drug Development
por: Naryzhnaya, Natalia V., et al.
Publicado: (2023)

Functional and cardioprotective effects of simultaneous and individual activation of protein kinase A and Epac
por: Khaliulin, Igor, et al.
Publicado: (2017)

Remote ischemic preconditioning triggers changes in autonomic nervous system activity: implications for cardioprotection
por: Abdul‐Ghani, Safa, et al.
Publicado: (2017)

Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation
por: Chun, Kook Jin, et al.
Publicado: (2010)

The Signaling Mechanism of Remote Postconditioning of the Heart: Prospects of the Use of Remote Postconditioning for the Treatment of Acute Myocardial Infarction
por: Ryabov, Vyacheslav V., et al.
Publicado: (2023)

κ-opioid receptor is involved in the cardioprotection induced by exercise training
por: Geng, Xiao, et al.
Publicado: (2017)

The role of cGMP and PKG in cardioprotection
por: Downey, James M, et al.
Publicado: (2009)

Delta Opioid Receptors: The Link between Exercise and Cardioprotection
por: Borges, Juliana P., et al.
Publicado: (2014)

Cardioprotection conferred by exercise training is blunted by blockade of the opioid system
por: Galvão, Tatiana F G, et al.
Publicado: (2011)

Novel Roles of Non-Coding RNAs in Opioid Signaling and Cardioprotection
por: Melo, Zesergio, et al.
Publicado: (2018)

The effect of an adaptation to hypoxia on cardiac tolerance to ischemia/reperfusion
por: Naryzhnaya, Natalia V., et al.
Publicado: (2023)

Hibernation-like state induced by an opioid peptide protects against experimental stroke
por: Borlongan, Cesar V, et al.
Publicado: (2009)

Use of antiarrhythmic drugs in elderly patients
por: Lee, Hon-Chi, et al.
Publicado: (2011)

SGLT2 Inhibitors and Their Antiarrhythmic Properties
por: Kolesnik, Ewald, et al.
Publicado: (2022)

Emerging Antiarrhythmic Drugs for Atrial Fibrillation
por: Saljic, Arnela, et al.
Publicado: (2022)

Lidocaine Infusion: An Antiarrhythmic With Neurologic Toxicities
por: Daraz, Yasmeen M, et al.
Publicado: (2022)

Recent Advances in Antiarrhythmic Drug Therapy
por: Saljic, Arnela, et al.
Publicado: (2023)

Better agonist for the opioid receptors
por: Badshah, Syed Lal, et al.
Publicado: (2018)

Structural basis for antiarrhythmic drug interactions with the human cardiac sodium channel
por: Nguyen, Phuong T., et al.
Publicado: (2019)

Optimal antiarrhythmic drug therapy for electrical storm
por: Sorajja, Dan, et al.
Publicado: (2015)

Cardiac Arrhythmias and Antiarrhythmic Drugs: An Autophagic Perspective
por: van Bavel, Joanne J. A., et al.
Publicado: (2018)

An antiarrhythmic approach to hydroxychloroquine-induced QT prolongation
por: Yetkin, E., et al.
Publicado: (2020)

Bradycardic and Antiarrhythmic Effects of the D-Limonene in Rats
por: do Nascimento, Gildenisson Araújo, et al.
Publicado: (2019)

Anti-arrhythmic properties of non-antiarrhythmic medications
por: Williams, Emmanuel Ato, et al.
Publicado: (2020)

Reduced-dose Antiarrhythmic Drugs: Valuable or Valueless?
por: Reiffel, James A.
Publicado: (2020)

Antiarrhythmic Medication in Neonates and Infants with Supraventricular Tachycardia
por: Bruder, Diana, et al.
Publicado: (2022)

Antiarrhythmic Drug Dosing in Children—Review of the Literature
por: Oeffl, Nathalie, et al.
Publicado: (2023)

Further Quinolizidine Derivatives as Antiarrhythmic Agents- 3
por: Tasso, Bruno, et al.
Publicado: (2023)

Physiological and Pathological Role of TRPV1, TRPV2 and TRPV4 Channels in Heart
por: Gorbunov, Alexandr S., et al.
Publicado: (2019)

Antenatal antiarrhythmic treatment for fetal tachyarrhythmias: a study protocol for a prospective multicentre trial
por: Miyoshi, Takekazu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jlcn1d2uo8rrv27p0e9bs78fjn